Cargando…
Considerations for Medications Commonly Utilized in the Oncology Population in the Intensive Care Unit
An increasing number of oncologic patients are presenting to the intensive care unit with complications from both their chronic disease states and cancer therapies due to improved survival rates. The management of these patients is complex due to immunosuppression (from the malignancy and/or treatme...
Autores principales: | Brown, Anne Rain Tanner, Horng, Michelle, Shigle, Terri Lynn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189427/ http://dx.doi.org/10.1007/978-3-319-74588-6_23 |
Ejemplares similares
-
Complications and Toxicities Associated with Cancer Therapies in the Intensive Care Unit
por: Rivera, Melvin J., et al.
Publicado: (2019) -
1583. The Utility of the Immunodeficiency Scoring Index (ISI) to Predict Outcomes of Coronavirus (HCoV) Infections in Hematopietic Cell Transplant (HCT) Recipients
por: Khawaja, Fareed, et al.
Publicado: (2018) -
Letermovir and its role in the prevention of cytomegalovirus infection in seropositive patients receiving an allogeneic hematopoietic cell transplant
por: Shigle, Terri Lynn, et al.
Publicado: (2020) -
American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Management and Clinical Management for COVID-19 in Hematopoietic Cell Transplantation and Cellular Therapy Patients in the United States
por: Mahmoudjafari, Zahra, et al.
Publicado: (2020) -
Pharmacogenomics of Medications Commonly Used in the Intensive Care Unit
por: Zhou, Shuqin, et al.
Publicado: (2018)